Reduction of renal function by angiotensin-converting enzyme inhibitors: Effect of verapamil

Nephron

Volumn 75, Issue 4, 1997, Pages 486-487

  Bitara, Rida ^a   Martmb, Belen ^b   Lopez Novoa, Jose M ^a   Madas Nunez, Juan F ^b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; VERAPAMIL;

ADULT; AGED; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; FEMALE; HUMAN; HYPERTENSION; KIDNEY FAILURE; LETTER; MALE; PRIORITY JOURNAL;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; VERAPAMIL;

EID: 0030940280     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189646     Document Type: Article

References (5)

1. Bojcslig M, Arnqvist H., Hermansson G., Kal-berg BE., Ludvigsson J: Declining incidence of nephropathy in insulin-dependent diabetes mellitus., N Engl., J Med 1994:330:15-18.
2. Kasiskc BL., Kalil RSN., Ma JZ., Liao M., Keane WF: Efl'ect of antihypertensive therapy on the Kidney in patients with diabetes: A meta regression analysis., Ann Intern Med 1993:118: 129-138.
3. Slataper R, Vicknair N, Sadler R., Bakris G: Comparative effects of different antihypertensive treatments on progression of renal disease., Arch Intern Med 1993:153:973-980.
4. Decesaris R., Ranieri G., Filitti V., Andriani A., Bonfantino MV: Effects of atenolol and enala-pril on kidney function in hypertensive diabetic patients., J Cardiovasc Pharmacol 1993:22: 208-214.
5. Gotloib L., Jaichcnko S., Fudin R., Shostok A: Severe reduction of renal function in hypertensive and/or diabetics induced by angiotensin-converting enzyme inhibitors., Nephron 1995: 71:230-231